Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Federal Use of Confidential Informants: Analysis and Guidelines
$108.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.''Green Studio'': Nature and the Arts in Therapy
02.Super-Spreading in Infectious Diseases
03.Lupus Renal Involvement: A Case-Based Atlas
04.New Research on Collective Behavior
05.The Evolving Human Primate: An Exploration through the Natural and Social Sciences
06.The Psychology of Effective Coaching and Management
07.Small Business in Brazil: Competitive Global Challenges
08.A-B-C: Analogues in Business Communication
09.Interprofessional Client-Centred Collaborative Practice: What Does it Look Like? How Can it be Achieved?
10.Economy, Politics and Governance Challenges for the 21st Century
11.Recent Advances on Using Virtual Reality Technologies for Rehabilitation
12.The Discourse of Digital Civic Engagement: Perspectives from the Developing World

Nova Science Publishers
© Copyright 2004 - 2016

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266